Outcomes of concurrent radiation with cisplatin versus cetuximab in locally-advanced head and neck squamous cell carcinoma (LAHNSCC).

被引：0
|
作者：
Ly Viet Do
Dowlatshahi, Morteza
Parekh, Zayd
Trevino, Richard
Eng, Richard
Fann, Karen
Dinh, Ngon
Lee, Raymond W.
Lee, Charlene Sen-Yee
Hla, Tin T.
机构：
[1] Canc Care Inst, San Jose, CA USA
[2] San Jose State Univ, San Jose, CA USA
[3] Reg Med Ctr San Jose, Dept ENT, San Jose, CA USA
[4] Raymond W Lee MD, San Jose, CA USA
[5] Reg Med Ctr San Jose, Dept Med Oncol, San Jose, CA USA
[6] Tin T Hla MD, San Jose, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e18007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18007
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC)
    Walsh, Lorraine
    Gillham, Charles
    Dunne, Mary
    Fraser, Ian
    Hollywood, Donal
    Armstrong, John
    Thirion, Pierre
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 98 (01) : 38 - 41
  • [2] Cisplatin Versus Cetuximab With Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Husain, Zain A.
    Burtness, Barbara A.
    Decker, Roy H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) : 396 - +
  • [3] Gemcitabine versus cisplatin concurrent with radiation therapy in locally advanced head and neck squamous cell carcinoma
    Mostafa, Magda
    Atif, Hesham
    Fawzy, Mahmoud
    Sakr, Amr Yehia
    Alashwah, Ahmed
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck
    Riaz, Nadeem
    Sherman, Eric
    Koutcher, Lawrence
    Shapiro, Lauren
    Katabi, Nora
    Zhang, Zhigang
    Shi, Weiji
    Fury, Mathew
    Wong, Richard
    Wolden, Suzanne
    Rao, Shyam
    Lee, Nancy
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (01): : 27 - 31
  • [5] Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro
    Zhang, Na
    Erjala, Kaisa
    Kulmala, Jarmo
    Qiu, Xueshan
    Sundvall, Maria
    Elenius, Klaus
    Grenman, Reidar
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 92 (03) : 388 - 392
  • [6] CONCURRENT CISPLATIN AND RADIATION VERSUS CETUXIMAB AND RADIATION FOR LOCALLY ADVANCED HEAD-AND-NECK CANCER
    Koutcher, Lawrence
    Sherman, Eric
    Fury, Matthew
    Wolden, Suzanne
    Zhang, Zhigang
    Mo, Qianxing
    Stewart, Laschelle
    Schupak, Karen
    Gelblum, Daphna
    Wong, Richard
    Kraus, Dennis
    Shah, Jatin
    Zelefsky, Michael
    Pfister, David
    Lee, Nancy
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : 915 - 922
  • [7] Cisplatin versus Cetuximab Given Concurrently with Definitive Radiation Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
    Ley, Jessica
    Mehan, Paul
    Wildes, Tanya M.
    Thorstad, Wade
    Gay, Hiram A.
    Michel, Loren
    Nussenbaum, Brian
    Trinkaus, Kathryn
    Adkins, Douglas
    [J]. ONCOLOGY, 2013, 85 (05) : 290 - 296
  • [8] Carboplatin versus cetuximab chemoradiation in cisplatin ineligible locally advanced head and neck squamous cell carcinoma.
    Thanikachalam, Kannan
    Krishnan, Jayasree
    Siddiqui, Farzan
    Ali, Haythem Y.
    Sheqwara, Jawad
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Safety and efficacy of concurrent carboplatin or cetuximab chemoradiation in cisplatin ineligible locally advanced head and neck squamous cell carcinoma
    Marinho, Joana
    Laranja, Andre
    Leao, Ines
    Joaquim, Ana
    Vieira, Claudia
    Dinis, Jose
    Soares, Andre
    Moreira, Diana
    [J]. ORAL ONCOLOGY, 2021, 118
  • [10] Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma A meta-analysis
    Tang, Wen-Hua
    Sun, Wei
    Long, Guo-Xian
    [J]. MEDICINE, 2020, 99 (36)
12345